The Aspergillus fumigatus Protein GliK Protects against Oxidative

Stress and Is Essential for Gliotoxin Biosynthesis by Gallagher, Lorna et al.
The Aspergillus fumigatus Protein GliK Protects against Oxidative
Stress and Is Essential for Gliotoxin Biosynthesis
Lorna Gallagher, Rebecca A. Owens, Stephen K. Dolan, Grainne O’Keeffe, Markus Schrettl, Kevin Kavanagh, Gary W. Jones,
and Sean Doyle
Department of Biology and National Institute for Cellular Biotechnology, National University of Ireland Maynooth, Maynooth, County Kildare, Ireland
The function of a number of genes in the gliotoxin biosynthetic cluster (gli) in Aspergillus fumigatus remains unknown. Here, we
demonstrate that gliK deletion from two strains of A. fumigatus completely abolished gliotoxin biosynthesis. Furthermore,
exogenous H2O2 (1 mM), but not gliotoxin, significantly induced A. fumigatus gliK expression (P 0.0101). While both mu-
tants exhibited significant sensitivity to both exogenous gliotoxin (P< 0.001) and H2O2 (P< 0.01), unexpectedly, exogenous
gliotoxin relieved H2O2-induced growth inhibition in a dose-dependent manner (0 to 10g/ml). Gliotoxin-containing organic
extracts derived from A. fumigatus ATCC 26933 significantly inhibited (P< 0.05) the growth of thegliK26933 deletion mutant.
The A. fumigatusgliK26933 mutant secreted metabolites, devoid of disulfide linkages or free thiols, that were detectable by re-
verse-phase high-performance liquid chromatography and liquid chromatography-mass spectrometry withm/z 394 to 396.
These metabolites (m/z 394 to 396) were present at significantly higher levels in the culture supernatants of the A. fumigatus
gliK26933 mutant than in those of the wild type (P 0.0024 [fold difference, 24] and P 0.0003 [fold difference, 9.6], respec-
tively) and were absent from A. fumigatusgliG. Significantly elevated levels of ergothioneine were present in aqueous mycelial
extracts of the A. fumigatusgliK26933 mutant compared to the wild type (P< 0.001). Determination of the gliotoxin uptake rate
revealed a significant difference (P 0.0045) between that of A. fumigatus ATCC 46645 (9.3 pg/mgmycelium/min) and the
gliK46645 mutant (31.4 pg/mgmycelium/min), strongly suggesting that gliK absence and the presence of elevated ergothioneine
levels impede exogenously added gliotoxin efflux. Our results confirm a role for gliK in gliotoxin biosynthesis and reveal new
insights into gliotoxin functionality in A. fumigatus.
Gliotoxin was discovered in 1936, and its structure was eluci-dated in 1943 (19, 38). Much initial interest in the molecule
was directed toward exploiting its antifungal activities; however,
after observations that gliotoxin exhibited growth-inhibitory ef-
fects against animal cells, it was posited as a putative anti-cancer or
organ transplant rejection agent, and a large number of subse-
quent studies investigated the mechanism of action of gliotoxin
against mammalian cell types (3, 24, 37).
Until recently, the mechanism of gliotoxin biosynthesis had
proven to be especially refractory to analysis, despite multiple
studies between 1960 and 1985 involving radiolabeled precursor
feeding and analysis of proteins produced during gliotoxin bio-
synthesis (2, 18). Since the discovery of the gliotoxin gene cluster
gli (14), now known to contain 13 genes, the function of a number
of cluster genes has been established by a combination of targeted
gene deletion and phenotypic and biochemical analyses (4, 10, 11,
13, 22, 31–33, 34, 36). gliZ [a Zn(II)2-Cys(6) binuclear cluster
domain transcription factor] deletion resulted in attenuation of
gli cluster expression and the absence of gliotoxin production (4).
The nonribosomal peptide synthetase GliP has been shown to be
essential for gliotoxin biosynthesis and to catalyze cyclo-L-pheny-
lalanyl-L-seryl formation from the cognate precursor amino acids
(1). Glutathione (GSH) has been implicated as the immediate
thiol source for both sulfur atoms in gliotoxin, and a reactive acyl
imine intermediate has been proposed to act as an acceptor for
glutathionylation catalyzed by the glutathione S-transferase GliG
(11, 31). The gliotoxin oxidoreductase, GliT, a key self-protection
gene against gliotoxin, is regulated independently of gliZ and cat-
alyzes disulfide bridge closure (32, 33). The involvement of GliC
has also been investigated (31), whereby GliC-mediated oxygen-
ation of a gliotoxin biosynthetic intermediate was essential for
subsequent thiolation catalyzed by GliG. Additionally, Schrettl et
al. (33) demonstrated that gliH was also essential for gliotoxin
biosynthesis, but that it did not play a role in self-protection
against gliotoxin. Comparative metabolomic analysis (13), using
two-dimensional nuclear magnetic resonance, has revealed the
presence of 19 gli-dependent metabolites (biosynthetic interme-
diates or shunt metabolites) in wild-type Aspergillus fumigatus
which are absent from the gliZ deletion strain (4). Interestingly,
this work also demonstrated that gliP and gliI deletion mutant
metabolomes did not contain any gliZ-dependent compounds.
While this might be expected for GliP absence, which normally
catalyzes the initiation step in gliotoxin biosynthesis (1), it is un-
clear why gliI (a putative aminotransferase) deletion resulted in
the complete absence of gliZ-dependent metabolites, although the
absence of gliZ and gliP expression in A. fumigatus gliI has been
noted (13).
Probably one of the most cryptic genes in the gli cluster is gliK
(CADRE identifier AFUA_6G09700; http://www.cadre-genomes
.org.uk [23]). However, the role of the protein encoded by gliK in
A. fumigatus has not been characterized to date. Interestingly,
fungi which contain the major facilitator superfamily (MFS),
rather than an ABC transporter associated with gliotoxin produc-
Received 4 April 2012 Accepted 7 August 2012
Published ahead of print 17 August 2012
Address correspondence to Sean Doyle, sean.doyle@nuim.ie.
Supplemental material for this article may be found at http://ec.asm.org/.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
doi:10.1128/EC.00113-12
1226 ec.asm.org Eukaryotic Cell p. 1226–1238 October 2012 Volume 11 Number 10
 o
n
 January 23, 2013 by NATL UNIV O
F IRELAND
http://ec.asm
.org/
D
ow
nloaded from
 
tion, also possess an adjacent gliK-type gene (28), whereas organ-
isms that contain the ABC transporter do not contain a gliK gene
within the relevant gene cluster. Conceivably, therefore, it is pos-
sible that the protein encoded by gliK is involved in epipolythio-
dioxopiperazine efflux with GliA, an MFS transporter in the gli
cluster. In any case, given the effective annotation of GliK as a
protein of unknown function and the presence of orthologs in a
range of fungal species (n  56 with 30% identity), functional
annotation of the gene is essential to further our knowledge of
epipolythiodioxopiperazine (ETP) biosynthesis.
Here, we demonstrate that deletion of gliK in two A. fumigatus
strains results in acquisition of significant gliotoxin and hydrogen
peroxide sensitivity, disrupted gliotoxin biosynthesis, metabo-
lome remodelling, and impaired gliotoxin uptake. Unexpectedly,
we further demonstrate that gliotoxin presence protects A. fu-
migatus against hydrogen peroxide-induced oxidative stress.
MATERIALS AND METHODS
Strains, growth conditions, and oligonucleotides. A. fumigatus strains
(see Table S1 in the supplemental material) were grown at 37°C in Asper-
gillus minimal medium (AMM). AMM contained 1% (wt/vol) glucose as
the carbon source, 5 mM ammonium tartrate as the nitrogen source, and
trace elements according to Pontecorvo et al. (29). Liquid cultures were
performed with 200 ml AMM or Czapek-Dox in 500-ml Erlenmeyer flasks
inoculated with 108 conidia. For growth assays, 103 conidia of the respec-
tive strains were point inoculated on AMM or Czapek-Dox plates con-
taining the relevant supplements and incubated for 72 h at 37°C. Oligo-
nucleotides used are listed in Table S2 in the supplemental material.
Generation of A. fumigatus mutant strains. For the generation of
both gliK strains, the bipartite marker technique was used (25). Briefly,
A. fumigatus strains ATCC 46645 and ATCC 26933 were cotransformed
with two DNA constructs, each containing an incomplete fragment of a
pyrithiamine resistance gene (ptrA) (21) fused to 1 and 1.1 kb of gliK
flanking sequences, respectively. These marker fragments shared a 557-bp
overlap in the ptrA cassette, which served as a potential recombination site
during transformation. During transformation, homologous integration
of each fragment into the genome flanking gliK allows recombination of
the ptrA fragments and generation of the intact resistance gene at the site
of recombination. Two rounds of PCR generated each fragment. First,
each flanking region was amplified from ATCC 46645 genomic DNA
using primers gliKP1 and gliKP4 for flanking region A (1.25 kb) and
gliKP2 and gliKP3 for flanking region B (1.2 kb). Subsequent to gel puri-
fication, the fragments were digested with SpeI and HindIII, respectively.
The ptrA selection marker was released from plasmid pSK275 (a kind gift
from Sven Krappmann, Goettingen, Germany) by digestion with SpeI and
HindIII and ligated with the two flanking regions A and B described
above. For generation of the gliK mutants, two overlapping fragments
were amplified from the ligation products using primers gliKP5 and op-
trA2 for fragment C (2.6 kb) and primers gliKP6 and optrA1 for fragment
D (2.2 kb). Subsequently, ATCC 46645 and ATCC 26933 were trans-
formed simultaneously with the overlapping fragments C and D. Com-
plementation of gliK was undertaken in the A. fumigatusgliK46645 strain
using selection on phleomycin and confirmed by Southern analysis (see
Fig. S1 in the supplemental material).
RNA isolation and real-time PCR. Fungal RNA was isolated and pu-
rified from A. fumigatus hyphae crushed in liquid nitrogen using the
RNeasy plant minikit (Qiagen). RNA was treated with DNase 1 (Invitro-
gen), and cDNA synthesis from mRNA (500 ng) was performed using a
first-strand transcription cDNA synthesis kit (Roche) with oligo(dT)
primers. The gene encoding calmodulin (AFUA_4G10050), which is con-
stitutively expressed in A. fumigatus, served as a control in reverse tran-
scription-PCR (RT-PCR) experiments (6). Real-time PCR was performed
using the LightCycler 480 Sybr green 1 master mix (Roche) on a Light-
Cycler 480 real-time PCR system as previously described (27). For real-
time PCRs, a 1/10 dilution of cDNA from each sample was used as a
template and each reaction was performed in triplicate.
Phenotypic assays. A. fumigatus wild-type and mutant strains were
incubated at 37°C for up to 72 h in the presence of either gliotoxin (0 to 20
g/ml), H2O2 (0 to 5 mM), gliotoxin and H2O2 (H2O2, 0 to 1 mM; glio-
toxin, 0 to 10 g/ml), or voriconazole (0 to 0.25 g/ml).
Analysis of gliotoxin and relatedmetabolite production. To analyze
gliotoxin and related metabolite production, A. fumigatus wild-type and
mutant strains were grown at 37°C for 48 h in AMM or Czapek-Dox
medium. Supernatants were chloroform extracted overnight, and frac-
tions were dried to completion under vacuum. Extracts were resolubilized
in methanol and analyzed using reverse-phase high-performance liquid
chromatography (RP-HPLC) and LC-mass spectrometry (LC-MS) as
previously described (30, 33). Reduction and alkylation (using 5=-iodoac-
etamidofluorescein; 5=-IAF) of organic extracts was performed as de-
scribed previously (11, 12). For intracellular metabolite analysis, mycelia
were lysed as described previously (7, 17) prior to reduction and alkyla-
tion (11, 12). Alternatively, total mycelial thiol quantitation was under-
taken using aldrithiol-4 (11 mg/ml in ethanol) analysis (35).
Determination of gliotoxin uptake rate. A. fumigatus ATCC 46645
(n 3 biological replicates) and gliK46645 (n 3) strains were grown at
37°C in minimal medium (MM), which contained 1% (wt/vol) glucose as
the carbon source, 20 mM L-glutamine as the nitrogen source, and trace
elements according to Pontecorvo et al. (29) for 24 h. At 24 h, gliotoxin (5
g/ml final) was added to the cultures, and 2-ml aliquots of supernatant
were removed at 0, 15, 30, and 45 min. After chloroform extraction, all
specimens were resuspended in methanol (55 l) followed by RP-HPLC
analysis (30, 33) for quantitation of residual gliotoxin. Corresponding
mycelia from replicate specimens were lyophilized and weighted.
Statistical analysis. All data were analyzed using built-in GraphPad
Prism (version 5.01) functions as specified. The level of significance was
set at P  0.05 (*), P  0.01 (**), and P  0.001 (***) unless otherwise
stated. Post hoc comparisons between groups were performed using the
Bonferroni multiple-comparison test unless otherwise stated. All graphs
were compiled using Graphpad Prism (version 5.01) unless otherwise
stated.
RESULTS
Deletion of gliK from A. fumigatus. A. fumigatus gliK mutants
were generated by transformation of A. fumigatus strains ATCC
46645 and ATCC 26933, respectively, as described in Materials
and Methods, using the bipartite marker technique and pyrithia-
mine selection, with modifications (21, 25). Targeted gliK dele-
tions in both ATCC 46645 and 26933 genetic backgrounds were
obtained at a frequency of 1/113 and 1/58 colonies screened, re-
spectively (see Fig. S1 in the supplemental material). These two
strains were chosen because A. fumigatus ATCC 46645 exhibits
extremely low-level gliotoxin secretion using MM, whereas the
ATCC 26933 strain is a potent gliotoxin producer (see below)
(33).
Gene expression analysis. gliKmRNA abundance was assessed
in A. fumigatus ATCC 46645 in different liquid medium types,
namely, Sabouraud medium, MM, and AMM. The cultures were
grown for 24, 48, and 72 h, respectively (Fig. 1). mRNA abundance
of gliK never exceeded a ratio of 1, indicating that it is at a much
lower level than the calmodulin reference gene (6). gliK mRNA
abundance was highest in AMM at 24 h yet was absent from Sab-
ouraud media at all time points. The mRNA abundance of gliK in
MM was equivalent at 24 and 48 h, whereas the abundance level
dropped dramatically at 72 h (P  0.1). In AMM cultures, the
highest mRNA abundance of gliK was at 24 h, which was reduced
considerably at 48 h (P 0.01) and was barely detectable at 72 h
(P 0.001). This indicates that gliK mRNA abundance is highest
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in MM and at early time points during culture. Since gliK mRNA
abundance was highest in AMM, this medium was chosen to con-
firm the absence of gliK mRNA in the A. fumigatus gliK46645
mutant (Fig. 1). gliKwas expressed inA. fumigatusATCC 46645 at
24 and 48 h, whereas the gliK46645 strain did not express gliK,
thereby confirming the deletion of gliK from the genome. gliK
expression was restored following complementation (see Fig. S2
in the supplemental material). Liquid cultures of A. fumigatus
ATCC 46645 in AMM were spiked with gliotoxin (5 g/ml final)
at 21 h and the cultures harvested at 24 h (33), and it was observed
that gliK mRNA abundance was not significantly increased in the
presence of gliotoxin (Fig. 1), indicating that gliK expression is not
controlled by the presence of gliotoxin. AMM cultures of A. fu-
migatus ATCC 46645 were also subjected to H2O2-induced oxida-
tive stress (1 mM) at 21 h, and the cultures were harvested at 24 h.
The abundance of gliK mRNA was significantly upregulated, from
a relative ratio of 0.1665 to 3.193 (P 0.0101), in the presence of
H2O2 (Fig. 1). A. fumigatus gliA is adjacent to gliK in the genome;
however, deletion of gliK did not prevent gliA expression in the
mutant strains (see Fig. S2).
Gliotoxin significantly inhibits growth of A. fumigatus
gliK. It has been demonstrated thatA. fumigatus is capable of self
protection against gliotoxin, and that deletion of gliT significantly
increased strain sensitivity to exogenous gliotoxin (32, 33). Both
gliK mutants were also significantly more sensitive to gliotoxin
(P 0.001), and a reduced growth rate was seen at all time points,
with the greatest difference in growth seen at 72 h (Fig. 2). After 72
h of growth on AMM plates, there was a significant decrease in the
radial growth of theA. fumigatusgliK46645 strain compared to the
wild-type strain when gliotoxin was present in the media (Fig. 2
and 3). The difference was highly significant at gliotoxin concen-
trations of 10 and 20 g/ml (P  0.001). A. fumigatus ATCC
46645 also exhibited a decreased radial growth (20%) at the
highest gliotoxin concentration used (20g/ml) compared to that
in media without gliotoxin, indicating that the A. fumigatus wild
type is sensitive to high levels of gliotoxin. The decrease in radial
growth due to the presence of exogenous gliotoxin was also ob-
served in the A. fumigatusgliK26933 strain at all gliotoxin concen-
trations tested (Fig. 2 and 3) and was highly significant at 10 and 20
g/ml gliotoxin, respectively (P 0.001). As seen forA. fumigatus
ATCC 46645, ATCC 26933 showed a decrease in growth ability in
gliotoxin (20g/ml), where there was a reduction in radial growth
of 21% compared to that in media without gliotoxin. The abun-
dance of gliT mRNA was determined in A. fumigatus gliK26933
andgliK46645 strains and was not found to be affected, indicating
that the sensitivity to gliotoxin observed inA. fumigatusgliK26933
and gliK46645 strains was not due to attenuated A. fumigatus gliT
expression (see Fig. S3 in the supplemental material).
H2O2 significantly inhibits growth of theA. fumigatusgliK
mutant. After 72 h of growth on AMM plates (containing 2 mM
H2O2), a significant difference in the radial growth of the A. fu-
migatus gliK46645 mutant compared to the wild type was ob-
served (P 0.01) (Fig. 2). In fact, the A. fumigatus gliK mutant
was unable to grow at 2 mM H2O2. At 1 mM H2O2, both strains
exhibited equivalent radial growth. The A. fumigatus gliK26933
strain showed the same pattern of growth on H2O2 as the
gliK46645 strain (Fig. 2), and there was significantly different ra-
dial growth at 2 mM H2O2 between the A. fumigatus ATCC 26933
and gliK26933 strains (P  0.01), as the mutant strain was inca-
pable of any growth at this concentration. This inability of the
mutant strain to grow was also observed at 3 mM H2O2, but this
was not found to be significant as the wild-type growth was also
FIG 1 (A) qRT-PCR analysis of gliK expression in A. fumigatus ATCC 46645 and the gliK46645 mutant in AMM at 24 h at 37°C. (B) Quantitative RT-PCR
(qRT-PCR) analysis of gliK expression at 24, 48, and 72 h inA. fumigatusATCC 46645 cultured in various media at 37°C. (C) qRT-PCR analysis of gliK expression
in A. fumigatus ATCC 46645 and the gliK46645 mutant, respectively, in AMM at selected time points at 37°C. (D) qRT-PCR analysis of gliK expression in A.
fumigatus ATCC 46645 in AMM at 24 h at 37°C, with and without exogenous gliotoxin spiked into the media. Column 1, gliK expression in A. fumigatus ATCC
46645; column 2, gliK expression in A. fumigatus ATCC 46645 spiked with gliotoxin (5 g/ml final concentration). (E) qRT-PCR analysis of gliK expression in
A. fumigatus ATCC 46645 in AMM at 24 h at 37°C, with and without hydrogen peroxide spiked into the media. Column 1, gliK expression in A. fumigatus ATCC
46645; column 2, gliK expression in A. fumigatus ATCC 46645 spiked with 1 mM hydrogen peroxide (final concentration). SAB, Sabouraud medium.
Gallagher et al.
1228 ec.asm.org Eukaryotic Cell
 o
n
 January 23, 2013 by NATL UNIV O
F IRELAND
http://ec.asm
.org/
D
ow
nloaded from
 
severely diminished. Conversely, no significant growth difference
between A. fumigatus ATCC 46645 and gliK46645 strains was ob-
served at 72 h on AMM plates in the presence of voriconazole (0 to
0.25 g/ml). Interestingly, at a low voriconazole concentration
(0.05 g/ml), radial growth of the gliK strains was greater than
that of the wild type; however, this difference was not significant
(data not shown).
Exogenous gliotoxin relieves H2O2 inhibition of A. fumiga-
tus growth. Figure 3 illustrates the inhibitory effects of gliotoxin
and H2O2, respectively, against A. fumigatus wild-type and gliK
strains on Czapek-Dox plates. Here, it can be seen that A. fumiga-
tus gliK mutant growth is completely inhibited at 1 mM H2O2;
however, gliotoxin addition (1 to 10 g/ml) significantly relieves
this inhibition (P  0.05) in a dose-dependent manner. More-
over, wild-type growth is similarly recovered in the presence of
gliotoxin (P 0.05). Clearly, gliotoxin presence acts to attenuate
the H2O2-induced oxidative stress independently of the gliK status
by either a direct or indirect mechanism (Fig. 3). Organic extracts
from A. fumigatus ATCC 26933 exert significant growth-inhibi-
tory effects against the gliK26933 mutant (Fig. 3D), while in re-
verse experimentation no inhibitory effect was detectable in
extracts fromgliK strains (Fig. 3E). Thus, we conclude that glio-
toxin is primarily responsible for the growth inhibition observed
in Fig. 3D.
Deletion of gliK abolishes gliotoxin biosynthesis and secre-
tion. A. fumigatus ATCC 46645 in AMM did not produce signif-
icant amounts of gliotoxin, therefore it was difficult to determine
if gliK deletion had an effect on gliotoxin production (data not
shown). RP-HPLC analysis of A. fumigatus ATCC 26933 showed
clear gliotoxin production (in AMM or Czapek-Dox) at a reten-
tion time (Rt) of 13.507 min, which is comparable to the standard
gliotoxin peak (13.516 min) (Fig. 4). A number of mutant-specific
metabolites with Rt of 11.757, 13.236, 14.257, 15.207, and 15.576
min were evident in cultures from the A. fumigatus gliK26933
strain (Fig. 4C). RP-HPLC analysis of NaBH4-reduced organic
extracts, with and without subsequent 5=-IAF alkylation (11, 12),
from wild-type and mutant cultures indicated the absence
of gliotoxin production by the deletion mutant (data not
shown). Matrix-assisted laser desorption ionization time-of-
flight (MALDI-TOF) MS analysis of reduced and alkylated or-
ganic extracts from the wild type confirmed the presence of the
gliotoxin [i.e., the presence of diacetamidofluorescein-gliotoxin,
or GT-(AF)2], while labeled gliotoxin was undetectable in organic
extracts from thegliK26933 mutant (Fig. 4D and E). LC-MS anal-
ysis confirmed the absence of gliotoxin production and revealed
the presence of metabolites [(M  H)  394 and 396] that are
significantly upregulated in culture supernatants of the A. fumiga-
tusgliK26933 mutant compared to the wild type (P 0.0024 [fold
difference 24.1] and P 0.0003 [fold difference 9.6], respec-
tively) (Fig. 5). These appear to be related compounds that differ
by 2 Da. This relationship is supported by the identical difference
between their relative daughter ion base peaks [(MH)  338
and 340, respectively]. The presence of dimers of these com-
pounds is also noted [(2 MH)  787 and 791, respectively].
These ions are all singly charged as deduced by interrogation of the
isotopic peaks of each compound. Importantly, the absence of
these secreted metabolites from A. fumigatus gliG supernatants
(see Fig. S4 in the supplemental material) confirms the occurrence
FIG 2 A. fumigatus gliK is sensitive to gliotoxin- and H2O2-mediated inhibition. Effect of gliotoxin on the growth of A. fumigatus ATCC 46645 and the
gliK46645 mutant (A) and ATCC 26933 and thegliK26933 mutant (B). Significant growth inhibition ofA. fumigatusgliK46645 andgliK26933 mutants is evident
at 72 h. Effect of hydrogen peroxide on the growth of A. fumigatus ATCC 46645 and thegliK46645 mutant (C) and A. fumigatus ATCC 26933 and thegliK26933
mutant (D). Significant growth inhibition of the A. fumigatus gliK26933 mutant is evident at 72 h.
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of a GliG-mediated reaction prior to that catalyzed by GliK.
LC-MS analysis of organic extracts of A. fumigatus wild-type super-
natants yielded spectra with dominant peaks between retention times
6.7 and 6.9 min which were attributable to the elution of gliotoxin
and confirmed by the presence of the parent ion [(MH)327.2]
and characteristic daughter ions [(MH)263, 245, 227] (Fig. 5).
Elevated levels of EGT in A. fumigatus gliK. Interestingly,
aldrithiol-4 titration revealed significantly more free thiol groups
per mg protein in thegliK26933 mutant than in wild-type mycelial
lysates (P 0.0028; n 3; fold difference, 2.2). This suggested the
presence of elevated amounts of free thiols, possibly in low-mo-
lecular-mass metabolite(s) related to disruption of gliotoxin bio-
synthesis, in the absence of gliK. However, no unique intracellular
metabolite was evident by RP-HPLC analysis of A. fumigatus
gliK mycelial lysates (data not shown). RP-HPLC analysis of
5=-IAF-treated mycelial lysates, either unreduced or subjected to
prior NaBH4-mediated reduction, indicated the presence of an
alkylated molecular species at an Rt of 11.7 min (Fig. 6A). Follow-
ing purification, total ion chromatograph (TIC) analysis of this
alkylated compound from A. fumigatus wild-type and gliK26933
strains exhibited retention times between 5.9 and 6.0 min, attrib-
utable to a compound with (MH) 617. 3 (Fig. 6B), and the
labeled metabolite was present at significantly higher levels in the
gliK26933 mutant than in the wild-type lysates (P 0.001; n 6;
fold difference, 4.96). No equivalent metabolite was detected in
the control samples. A number of doubly charged molecular spe-
cies were also detected [(M 2H)2 309.2, 287.2], formed as a
result of double protonation of the molecular ion [(M H) 
617. 3] or of daughter ions [(MH) 573.3], respectively (Fig.
6C and D). The mass of the intracellular unlabeled metabolite,
present at elevated levels in the A. fumigatus gliK mutant, was
229 Da, which was deduced by subtracting the acetamidofluores-
cein mass from that of the molecular ion of the labeled compound
(617.3  388.3 Da  229 Da). Importantly, alkylation of pure
GSH, followed by LC-MS analysis, revealed the expected mass of
acetamidofluorescein-glutathione (m/z  695) (Fig. 6E) at a dif-
ferent Rt (6.1 min) compared to that of the monothiol metabolite
from A. fumigatus (Fig. 6C). Moreover, MS/MS fragmentation
indicated a neutral loss of 129 Da, corresponding to the loss of the
	-glutamyl moiety from GSH (40). This was not detectable fol-
lowing LC-tandem MS (MS/MS) analyses of the fungal monothiol
species, thereby eliminating the possibility that it is GSH. This
compound was subsequently identified, for the first time in A.
fumigatus, as ergothioneine (EGT; 229 Da; C9H15N3O2S), which
exists as a tautomer of a thiol and thione form (Fig. 6F) (2a). The
fragmentation pattern observed included a neutral loss of 44
(617.3 to 573.3) corresponding to the loss of COO, a neutral loss
of 59 (573.3 to 514.3) corresponding to N(CH3)3
, and a neutral
loss of 126.2 (514.3 to 388.1) corresponding to C5N2H6S. This
MS/MS analysis correlated with the fragmentation pattern ob-
served for the selenium analog of ergothioneine, selenoneine (39).
Consequently, this analysis confirmed the presence of elevated
levels of ergothioneine in A. fumigatus ATCC 26933 following
deletion of the gliK gene. Ergothioneine levels in the gliKC strain
returned to those found in the wild-type (ATCC 46645) (see Fig.
S5 in the supplemental material), thereby confirming the recon-
stitution of gliK in the A. fumigatus gliK46645 mutant.
gliK deletion significantly impedes gliotoxin efflux from A.
fumigatus.RP-HPLC analysis confirmed that althoughA. fumiga-
tus ATCC 46645 produced a residual amount of gliotoxin, 0.3

0.13 (means 
 standard deviations) ng/mg mycelium, the A. fu-
migatus gliK46645 mutant did not produce gliotoxin (Fig. 7A).
Thus, the uptake of exogenously added gliotoxin (5 g/ml), by
both wild-type andgliK46645 strains in liquid cultures over 0 to 45
min, was determined by quantifying the residual gliotoxin con-
centration in supernatants. Significantly less gliotoxin was present
in culture supernatants of theA. fumigatusgliK46645 mutant than
in that of ATCC 46645 after gliotoxin exposure at 15 min (P 
0.0102) and 30 min (P  0.0045) (Fig. 7B). This implied that
gliotoxin was either effluxing more slowly from the mycelia of A.
fumigatusgliK46645 after uptake or is removed more rapidly from
the supernatant. After 45 min, the level of gliotoxin increased in
thegliK culture supernatants, possibly because alternative efflux
mechanisms had been activated. The uptake rate of gliotoxin by
the wild-type and mutant strains was calculated at 15-min inter-
vals. At 15 min, the A. fumigatus gliK46645 mutant exhibited a
gliotoxin uptake rate of 31.443 pg/mg mycelia/min, more than
three times that of A. fumigatus ATCC 46645 (9.337 pg/mg myce-
lia/min) (P 0.0039). The wild-type strain exhibited a relatively
constant level of gliotoxin for 45 min in the supernatant, indicat-
ing that the wild-type strain displayed a balance between uptake
and efflux of gliotoxin (Fig. 7B and C). In the A. fumigatus
gliK46645 mutant, gliotoxin levels began to stabilize in the super-
natant after the initial uptake in the first 15 min of exposure. Thus,
it appears that deletion of gliK has disrupted a gliotoxin efflux
mechanism in A. fumigatus, because elevated (or constant) glio-
toxin levels in A. fumigatus gliK46645 mutant culture superna-
tants would have been predicted if gliK encoded a component of a
gliotoxin uptake mechanism.
DISCUSSION
Although orthologs ofA. fumigatus gliK exist in other fungi, bioin-
formatic analysis of gliK in terms of comparative sequence or con-
served domain analysis has provided no definitive information as
to its function (28). Here, we reveal that gliK deletion from A.
fumigatus results in acquisition of gliotoxin- and H2O2-sensitive
phenotypes and loss of gliotoxin production in two strains. Fur-
ther, we observe that H2O2 induces gliK expression and, unexpect-
edly, that gliotoxin addition significantly relieves the H2O2-in-
duced growth inhibition in both A. fumigatus wild-type andgliK
strains. The presence of (i) significantly elevated levels of external
metabolites of m/z 394 to 396, in addition to (ii) an elevation in
intracellular ergothioneine levels in A. fumigatus gliK strains,
were determined. Finally, a significantly reduced rate of exoge-
FIG 3 Individual and combined effects of gliotoxin (0 to 10 g/ml) and H2O2 on wild-type A. fumigatus and the gliK mutant on Czapek-Dox medium. (A)
Gliotoxin (10 g/ml) significantly inhibits gliK mutant growth. (B) H2O2 (1 mM) completely inhibits the growth of the A. fumigatus gliK mutant compared
to that of the wild type. (C) Gliotoxin (1 to 10g/ml) significantly relieves H2O2-mediated growth inhibition in a dose-dependent manner. (D) Organic extracts
from A. fumigatus ATCC 26933 culture supernatants (containing gliotoxin at 0 to 10g/ml) exhibit significant growth inhibition of thegliK mutant compared
to the wild type. (E) Organic extracts from A. fumigatus gliK culture supernatants (gliotoxin was absent, but equivalent [Eq] volumes of organic extract were
used) do not affect wild-type or gliK mutant growth.
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FIG 4 RP-HPLC confirms gliotoxin absence from A. fumigatusgliK. Standard gliotoxin with a retention time of 13.51 min (A), ATCC 26933 with gliotoxin at
an Rt of 13.50 min (B), and the gliK26933 mutant lacking a corresponding gliotoxin peak (C). Detection was at 254 nm. (D) MALDI-TOF analysis reveals
diacetamidofluorescein-gliotoxin [GT-(AF)2] (m/z 1102.94) (12) following reduction and alkylation of organic extracts from A. fumigatus ATCC 26933. (E)
GT-(AF)2 is not present in organic extracts of the A. fumigatus gliK
26933 mutant.
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nously added gliotoxin efflux from A. fumigatus gliK compared
to wild-type strains is observed. This finding may be due to either
gliotoxin reduction by ergothioneine or to consequent gliK in-
volvement in gliotoxin secretion.
Targeted deletion of gliK in two A. fumigatus strains was
achieved, and the integrity and expression of the adjacent gene
(gliA) was unaffected by the deletion strategy employed (see Fig.
S2 in the supplemental material). Likewise, it has been confirmed
that deletion of gliT, and consequent phenotypes observed, were
gene specific and not caused by alterations in the structure or
expression of the surrounding genes, gliF and gliH (33). gliK dele-
tion resulted in the complete absence of cognate gene expression,
thereby ensuring that all subsequent phenotypes were directly
caused by GliK absence. The maximum yield of gliotoxin is highly
influenced by growth conditions, especially the culture media
(20). Consequently, assessment of gliK expression under different
culture conditions was undertaken to establish optimal condi-
tions for assessment of the relationship between gliK expression
and gliotoxin production. gliK expression was found to be highest
at 24 h in AMM, so this time point and medium were used in all
subsequent gliK expression analyses and gliotoxin uptake studies.
gliK expression was also evident in MM at 24 and 48 h, although it
had decreased by 72 h, indicating that gliK is normally expressed
early on and may not be required in the later stages of fungal
culture. gliK expression was undetectable in Sabouraud media at
any time point in wild-type and A. fumigatus gliK46645 mutant
cultures, thereby confirming gliK absence from the latter strain.
Genes in the gliotoxin biosynthetic cluster have been associ-
ated with protection against gliotoxin. For example, gliT, a glio-
toxin oxidoreductase, has been shown to play a self-protection
FIG 5 (A) Total ion chromatograph (TIC; overlaid) of organic extracts from wild-type (black) and gliK26933 mutant (red) culture supernatants. (B) Gliotoxin
(m/z 327.2) was identified in the mass spectra from the wild-type culture supernatant but was not found in the gliK26933 mutant culture supernatant.
Comparative profiling identified compounds (m/z 394.3 and 396.3) that were present at higher concentrations in thegliK26933 mutant than in wild-type culture
supernatants. Mass spectra from the molecular species, m/z 394.3 (C) and m/z 396.3 (D), are shown. Selected parent ions from MS are indicated (}), with
resultant MS/MS spectra included directly below.
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role against gliotoxin, as disruption of this gene renders the fungus
completely sensitive to exogenous gliotoxin (5 g/ml) (32, 33).
However, no alteration in sensitivity to H2O2 was observed for the
A. fumigatus gliT mutant. The gliotoxin transporter, gliA, was
shown to confer resistance to gliotoxin in the Leptosphaeriamacu-
lanssirA mutant (15). In the present study, deletion of gliK in A.
fumigatus ATCC 46645 and ATCC 26933 resulted in mutant
strains that became highly sensitive to exogenous gliotoxin and
H2O2 but were unaffected by exposure to the antifungal voricona-
zole. Although a statistically significant difference in growth rates
was observed betweenA. fumigatuswild-type and respectivegliK
strains, addition of gliotoxin did not completely suppress growth
of gliK46645 and gliK26933 mutants, even at high concentrations
of gliotoxin (20 g/ml). Thus, observed gliotoxin sensitivity was
less apparent than that previously encountered for A. fumigatus
gliT (32, 33). Hence, we hypothesized that although gliK plays a
role in self protection against gliotoxin, it is more likely that any
metabolite (biosynthetic intermediate or shunt metabolite) pro-
duced consequent to gliK deletion mediates sensitivity to exoge-
nous gliotoxin. We further conclude that it is not simply the loss of
gliK which sensitizes A. fumigatus to gliotoxin, since gliK is not
expressed in the A. fumigatus gliZ mutant, and this strain exhib-
its a wild-type gliotoxin phenotype (33).
Although exogenous gliotoxin (5 g/ml) had no effect on gliK
expression in A. fumigatus ATCC 46645, we found that H2O2-
induced oxidative stress resulted in an almost 20-fold increase
(0.1665 versus 3.193) in gliK expression (P 0.0101). Moreover,
exposure of A. fumigatus wild-type, gliK26933, and gliK46645
strains to hydrogen peroxide also resulted in differential growth
responses. Here, increased mutant sensitivity to hydrogen perox-
ide (2 mM) was observed whereby the mutant strains were unable
to grow, unlike both wild-type strains, which exhibited approxi-
mately 50% growth. Since gliotoxin biosynthesis is impaired in the
A. fumigatus gliK mutant, these observations suggest that either
gliK absence, a specific biosynthetic intermediate, or ergothion-
eine presence augments H2O2-mediated oxidative stress. Rele-
vantly, it has been demonstrated that theA. fumigatusgliG strain
does not exhibit increased sensitivity to gliotoxin or H2O2 (11).
Indeed, it has also been noted that gliotoxin may play a role in
regulating the redox status of A. fumigatus (7, 33). However, de-
spite extensive analyses, no evidence of enhanced gliotoxin efflux
was detectable following exposure of A. fumigatus to H2O2.
In an attempt to unravel the unique response of the A. fumiga-
tus gliK mutant to gliotoxin- and H2O2-mediated oxidative
stress, we performed coaddition experiments to determine if the
individual inhibitory effects of gliotoxin and H2O2 were additive.
To our surprise, we found that gliotoxin actually relieved H2O2-
induced growth inhibition of both wild-type and gliK deletion
strains of A. fumigatus. Relevantly, it has been noted that gliotoxin
catalyzes H2O2 reduction and that it was a novel thioredoxin sub-
strate, because no H2O2-reducing activity was evident in the ab-
sence of thioredoxin reductase or thioredoxin in mammalian cells
(8). These authors also demonstrated that gliotoxin inhibited the
H2O2-induced angiogenesis of human umbilical vein endothelial
cells. However, at present the precise mechanism for our observa-
tions in A. fumigatus remains undetermined, and work is under
FIG 6 RP-HPLC analysis of A. fumigatus ATCC 26933 wild-type (black) andgliK26933 mutant (red) mycelial lysates with no reduction prior to 5=-IAF labeling
(NR plus 5=-IAF). (A) Absorbance detection at 254 nm is shown for all samples. 5=-IAF was detected at Rt of 12.068 and 14.074 min (*). A 5=-IAF-labeled
metabolite (AF11.7) eluted at an Rt of 11.706 min (indicated by arrow). (B) Total ion chromatograph (TIC) of the 11- to 12-min fraction from RP-HPLC analyses
of 5= IAF-labeled mycelial lysates ofA. fumigatusATCC 26933 wild-type (black) andgliK26933 mutant (red) strains. A control sample, comprising the equivalent
fraction from 5=-IAF labeling of lysate buffer, is also shown (green). MSn, multiple-stage mass spectrometry. (C) Mass spectra of the compounds observed at
retention times of 5.9 to 6.0 min from each of theA. fumigatus samples revealed a singly charged molecule with (MH) 617.3 along with two doubly charged
molecules withm/z 309.2 and 287.3, respectively. (D) Compounds were not found in the mass spectra of the control. MS/MS (MS2) analyses of each of these three
ions was carried out. (E) Mass spectra of the compound observed at retention times of 6.0 to 6.2 min in 5=-IAF-labeled GSH revealed a singly charged molecule
with (MH) 695.3, corresponding to acetamidofluorescein-glutathione, along with two doubly charged molecules withm/z 348.2 and 283.6, respectively.
(F) Ergothioneine.
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way to explore this phenomenon. Notably, organic extracts of
wild-type culture supernatants inhibited gliK growth, yet the op-
posite was not observed. This result is in accordance with Cole-
man et al. (9), who observed that gliotoxin-deficient organic ex-
tracts of the A. fumigatus gliP mutant did not exhibit inhibitory
properties against Candida albicans.
Gliotoxin production by A. fumigatus ATCC 46645 was at too
low a level to reliably assess if thegliKmutation had any effect on
gliotoxin production. This was not the case forA. fumigatusATCC
26933, where the amount of gliotoxin produced was readily de-
tectable prior to NaBH4-mediated reduction (11, 12), and subse-
quent reduction confirmed gliotoxin presence by the appearance
of the dithiol form at a reduced retention time (3) in organic
extracts of the wild-type culture supernatants (data not shown). A
method for gliotoxin detection by alkylating the reduced form of
gliotoxin with 5=-iodoacetamidofluorescein (5=-IAF) followed by
RP-HPLC or MALDI-MS identification (12) provided confirma-
tory data for gliotoxin production by the A. fumigatus wild-type
strain and deficiency in gliK strains, respectively. Thus, we con-
clude that gliotoxin production and secretion by the gliK26933
mutant was abolished. However, significantly elevated levels of
two hydrophobic metabolites were detectable in organic extracts
of the gliK26933 mutant, which exhibited m/z 394 to 396 follow-
ing LC-MS analysis. These metabolites did not contain free thiols,
and as noted above they did not possess growth-inhibitory
properties associated with organic extracts of wild-type organic
extracts. Also, the observed m/z did not correspond to any
metabolite present in the A. fumigatus wild-type intracellular
metabolome (13) or secretome of the A. fumigatus gliG strain
(11, 31). Moreover, this mass (393 to 395 Da) is greater than that
of gliotoxin, 326 Da, and strongly suggests the presence of either a
shunt metabolite(s) or biosynthetic intermediate of higher mass
than gliotoxin, as previously observed (31). Our analyses revealed
that these metabolites were detectable following deletion of gliT
but absent from the gliG deletion strain. This means that the pres-
ence of these metabolites (m/z 394 to 396) is GliG dependent, and
that accumulation of these intermediates/shunt metabolites oc-
curs in the absence of GliK. This positions GliK in the gliotoxin
biosynthetic pathway as catalyzing a reaction after the diglutathio-
nylation event effected by GliG but preceding GliT-mediated di-
sulfide oxidation. Future purification and structural characteriza-
tion will enable unambiguous identification of the nature of these
extracellular metabolites.
Intriguingly, significantly elevated levels of ergothioneine were
detected in aqueous extracts of A. fumigatus gliK26933 mutant
mycelial lysates compared to the wild type. The biosynthetic
pathway of ergothioneine, in mycobacteria, involves sulfuriza-
tion through incorporation of 	-glutamylcysteine (	GC) (33a).
Observation of increased ergothioneine levels in gliK may sup-
port a putative trans function of GliK as a 	-glutamyl cyclotrans-
ferase (GGCT), with deletion of this gene resulting in reduced
catabolism of the substrate for ergothioneine biosynthesis. Inter-
estingly, GliK appears in part to encode a gamma-glutamyl cyclo-
transferase-like (GGCT-like) domain that is responsible for cata-
lyzing the formation of pyroglutamic acid (5-oxoproline) from
dipeptides containing 	-glutamate (26).
Based on our observations that both A. fumigatus gliK mu-
tants were deficient in gliotoxin biosynthesis and acquired in-
creased sensitivity to exogenous gliotoxin (5 g/ml), the relative
uptake rates of exogenous gliotoxin by A. fumigatus ATCC 46645
and gliK46645 strains was undertaken to further investigate the
role of gliK. Here, we reasoned that if thegliK46645 mutant could
take up gliotoxin normally but exhibit impaired efflux compared
to the wild type, then the exogenous levels of gliotoxin should
decrease more rapidly, and to a greater extent, in gliK46645 cul-
tures. The ATCC 46645 strain was selected because the low levels
of endogenous gliotoxin produced (33) would not interfere with
measurement of exogenously added gliotoxin. Previous work
(Stephen Carberry, personal communication) had suggested that
a 45-min experimental period would be optimal for assessment of
gliotoxin uptake by A. fumigatus. At 15 min after gliotoxin addi-
tion, there was a significantly lower level of gliotoxin present in A.
fumigatus gliK46645 mutant supernatants compared to the wild
FIG 7 (A) Gliotoxin (GT) production in AMM liquid cultures from ATCC
46645 andgliK46645 strains. (B) The amount of gliotoxin remaining in culture
supernatants at time intervals after exposure of A. fumigatus ATCC 46645 and
gliK46645 strains to gliotoxin (5 g/ml) over a 0- to 45-min duration. (C)
Gliotoxin uptake rate by A. fumigatus ATCC 46645 and gliK46645 strains in
liquid cultures at selected time points.
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type (P 0.0102). This difference was also evident at 30 min (P
0.0045); however, at 45 min the level of exogenous gliotoxin in
supernatants of the A. fumigatus gliK46645 mutant began to in-
crease and no statistically significant difference in exogenous glio-
toxin levels between mutant and wild type was apparent (wild type
versus the gliK46645 mutant, 0.831 
 0.356 and 0.668 
 0.171
ng/mg mycelium, respectively). This is possibly due to activation
of the autoprotective gliT response, which has also been proposed
to facilitate gliotoxin efflux from A. fumigatus (33). A differential
gliotoxin uptake rate for the phytopathogens Pythium ultimum
and Rhizoctania solani, expressed as g · mg dry weight1, has
been reported (16). Interestingly, these authors noted that glio-
toxin uptake was complete within 1 min, and they observed pas-
sive, adsorptive-type kinetics and that uptake was significantly
lower in gliotoxin-resistant strains. Overall, we propose that ex-
ogenous gliotoxin levels drop rapidly (0 to 30 min) in the A. fu-
migatus gliK46645 mutant due to impaired efflux, which may be
due to reduction of gliotoxin by ergothionine, which prevents its
release, or because gliK acts in association with gliA, the MFS
transporter (15), to maintain gliotoxin homeostasis in A. fumiga-
tus and to facilitate gliotoxin efflux under normal conditions. It
should be noted that if gliK had been involved in gliotoxin uptake,
one would have observed either no change or an elevation of ex-
ogenous gliotoxin levels in the A. fumigatus gliK46645 mutant.
This was not observed. Moreover, our data suggest that GliT (33)
participates in gliotoxin secretion, possibly in conjunction with
GliA functionality as an efflux pump (15), which may partly
compensate for the loss of GliK, provided that the amount of
gliotoxin does not exceed the levels with which the cell can
cope. Sirodesmin, a related ETP toxin, is produced by L. macu-
lans, and its biosynthesis is encoded by a multigene cluster analo-
gous to that which encodes gliotoxin production in A. fumigatus
(15). Deletion of sirA, the sirodesmin transporter gene, also led to
increased sensitivity to exogenous sirodesmin and gliotoxin. In-
terestingly, introduction of A. fumigatus gliA recovered resistance
to exogenous gliotoxin (10 M), but not sirodesmin, in L. macu-
lans sirA::gliA. Production and secretion of sirodesmin actually
increased by 39% in the L. maculans sirA strain compared to the
wild type, leading to speculation about the presence of alternative
toxin efflux mechanisms (15). Further, Bradshaw et al. (5) sug-
gested that the MFS transporter encoded by dotC in Dothistroma
septosporum was not the major efflux pump for dothistromin and
concluded that there are other factors besides DotC facilitating the
efflux of the toxin. Thus, toxin secretion may be multifactorial and
require not only efflux pumps but also defined intracellular con-
ditions to enable efficient toxin-pump interaction as part of the
secretion process.
In summary, targeted deletion of A. fumigatus gliK, a compo-
nent of the gliotoxin biosynthetic cluster, in two fungal strains
which produce low and high levels of gliotoxin, respectively, re-
sulted in acquisition of (i) sensitivity to exogenous gliotoxin, (ii)
impaired biosynthesis of gliotoxin, (iii) an altered extra- and in-
tracellular metabolome, and (iv) increased sensitivity to H2O2.
We identify gliK as a component of the gliotoxin biosynthetic
system in A. fumigatus and propose that decreased efflux of exog-
enously added gliotoxin in theA. fumigatusgliKmutant is due to
significantly elevated levels of ergothioneine which may reduce
gliotoxin and impede efflux. Future work will investigate these
hypotheses and dissect the mechanistic action of GliK.
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